The effect of previous coronary artery stenting on short- and intermediate-term outcome after surgical revascularization in patients with diabetes mellitus

Journal of Thoracic and Cardiovascular Surgery

Volumn 138, Issue 2, 2009, Pages 316-323

  Tran, Henry A ^a   Barnett, Scott D ^a   Hunt, Sharon L ^a   Chon, Andrew ^a   Ad, Niv ^a  

^a INOVA HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVASCULARIZATION; SURGICAL MORTALITY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETREATMENT; STENTS; TREATMENT OUTCOME;

EID: 67651115657     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2009.03.004     Document Type: Article

References (32)

1. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomized controlled trial. Lancet 360 (2002) 965-970
2. Rodriquez A.E., Baldi J., Fernandez-Pereira C.F., Navia J., Rodriguez-Alemparte M., Delacasa A., et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46 (2005) 582-588
3. Serruys P.W., Ong A.T.L., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
4. Hannan E.L., Racz M.J., Walford G., Jones R.H., Ryan T.J., Bennett E., et al. Long-term outcomes of coronary-artery bypass grafting verses stent implantation. N Engl J Med 352 (2005) 2174-2183
5. Niles N.W., McGrath P.D., Malenka D., Quinton H., Wennberg D., Shubrooks S.J., et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 37 (2001) 1008-1015
6. Kohsaka S., Goto M., Virani S., Lee V.V., Aoki N., Elayda M.A., et al. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease. J Thorac Cardiovasc Surg 16 (2008) 500-506
7. Booth J., Clayton T., Pepper J., Nugara F., Flather M., Sigwart U., et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation 118 (2008) 381-388
8. Mehran R., Dangas G.D., Kobayashi Y., Lansky A.J., Mintz G.S., Aymong E.D., et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 43 (2003) 1328-1354
9. Schofer J., Schlüter M., Rau T., Hammer F., Haag N., and Mathey D.G. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol 35 (2000) 1554-1559
10. Hoffman S.N., TenBrook J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty: one to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
11. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
12. Thielmann M., Neuhauser M., Knipp S., Kottenberg-Assenmacher E., Marr A., Pizanis N., et al. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 134 (2007) 470-476
13. Shroyer A.L., Cooms L.P., Peterson E.D., Eiken M.C., DeLong E.R., Chen A., et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 75 (2003) 1856-1865
14. Malenka D.J., Leavitt B.J., Hearne M.J., Robb J.F., Baribeau Y.R., Ryan T.J., et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation 112 suppl (2005) 1371-1376
15. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
16. Van Belle E., Bauters C., Hubert E., Bodart J.C., Abolmaali K., Meurice T., et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96 (1997) 1454-1460
17. Kornowski R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Bucher T.A., et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 95 (1997) 1366-1369
18. Hannan E.L., Wu C., Walford G., Culliford A.T., Gold J.P., Smith C.R., et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358 (2008) 331-341
19. Javaid A., Steinberg D., Buch A.N., Corso P.J., Boyce S.W., Pinto T.L., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 116 (2007) I200-I206
20. Thielmann M., Leyh R., Massoudy P., Neuhäuser M., Aleksic I., Kamler M., et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 114 suppl I (2006) 1441-1447
21. Massoudy P., Thielmann M., Lehmann N., Marr A., Kleikamp G., Maleszka A., et al. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis. J Thorac Cardiovasc Surg 137 (2009) 840-845
22. Hassan A., Buth K.J., Baskett R.J., Ali I.S., Maitland A., Sullivan J.A., et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 150 (2005) 1026-1030
23. Rao C., Stanbridge R.D.L., Chikwe J., Pepper J., Skapinakis P., Aziz O., et al. Does previous percutaneous coronary stenting compromise the long-term efficacy of subsequent coronary artery bypass surgery? A Microsimulation Study. Ann Thorac Surg 85 (2008) 501-507
24. Chocron S., Baillot R., Rouleau J.L., Warnica W.J., Block P., Johnstone D., et al. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study. Eur Heart J 29 (2008) 673-679
25. Toutouzas K., Colombo A., and Steanadis C. Inflammation and restenosis after percutaneous coronary interventions. Eur Heart J 25 (2004) 1679-1687
26. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 26 (2005) 2493-2519
27. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Rickenbacher P., Hunziker P., Mueller C., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
28. Serruys P., and Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents?. Circulation 115 (2007) 1433-1439
29. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 35 (2005) 2088-2092
30. Kulik A., Levin R., Ruel M., Mesana T.G., Solomon D.H., and Choudhry N.K. Patterns and predictors of statin use after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 134 (2007) 932-938
31. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., Strauch J., Wittwer T., Dorge H., et al. Impact of perioperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30000 patients. Eur Heart J 29 (2008) 1548-1559
32. Pan W., Pintar T., Anton J., Lee V., Vaughn W.K., and Collarg C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 (2004) II45-II49